CIPRODEX is a Auricular (otic) Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Ciprofloxacin Hydrochloride; Dexamethasone.
Product ID | 0078-0799_3e2cf3ea-a8f2-42e3-8424-9a6d6f0a4cb3 |
NDC | 0078-0799 |
Product Type | Human Prescription Drug |
Proprietary Name | CIPRODEX |
Generic Name | Ciprofloxacin And Dexamethasone |
Dosage Form | Suspension/ Drops |
Route of Administration | AURICULAR (OTIC) |
Marketing Start Date | 2020-07-28 |
Marketing Category | NDA / NDA |
Application Number | NDA021537 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE |
Active Ingredient Strength | 3 mg/mL; mg/mL |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Quinolone Antimicrobial [EPC],Quinolones [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-07-28 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0065-8533 | CIPRODEX | ciprofloxacin and dexamethasone |
0078-0799 | CIPRODEX | ciprofloxacin and dexamethasone |
21695-969 | CIPRODEX | ciprofloxacin and dexamethasone |
68071-1629 | CIPRODEX | ciprofloxacin and dexamethasone |
71205-309 | CIPRODEX | ciprofloxacin and dexamethasone |
0781-6186 | Ciprofloxacin and Dexamethasone | ciprofloxacin and dexamethasone |
16714-628 | Ciprofloxacin and Dexamethasone | Ciprofloxacin and Dexamethasone |
43598-326 | Ciprofloxacin and Dexamethasone | Ciprofloxacin and Dexamethasone |
62756-427 | Ciprofloxacin and dexamethasone | Ciprofloxacin and dexamethasone |
63629-8797 | Ciprofloxacin and Dexamethasone | ciprofloxacin and dexamethasone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CIPRODEX 75935885 2513415 Live/Registered |
Bayer Aktiengesellschaft 2000-03-06 |